National Health Investors, Inc. (NHI) Stock Analysis
Range Bound setup
Real Estate · REIT - Healthcare Facilities
Sell if holding. Analyst target reached at $76.69 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Real Estate): -1.2.
National Health Investors is a self-managed healthcare REIT with $2.7B in Real Estate Investments across 176 properties in 32 states leased via triple-net leases, plus a $634.3M SHOP segment of 26 senior housing communities. Total revenues were $375.6M in 2025, comprising 72.3%... Read more
Sell if holding. Analyst target reached at $76.69 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Real Estate): -1.2. Chart setup: RSI 51 mid-range, Bollinger mid-band. Score 5.1/10, high confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent Developments — National Health Investors, Inc.
Latest news
- National Health Investors CFO to retire; successor named - MSN — MSN neutral
- M&T Bank Corp Buys Shares of 39,236 National Health Investors, Inc. $NHI - MarketBeat — MarketBeat neutral
- Nhi Hiep Brick-Tile Co-Operation Faces Valuation Shift Amid Mixed Performance Indicators - Markets Mojo — Markets Mojo neutral
- National Health Investors is the most oversold real estate stock as Q1 earnings roll on - MSN — MSN negative
- National Health Investors sells portfolio for $560M - Nashville Post — Nashville Post positive
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Revenue shrinking — -2.6% YoY. Growth thesis broken unless recovery story develops.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $76.69 — A.R:R is negative (-0.2) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Sector modifier (Real Estate): -1.2. Chart setup: RSI 51 mid-range, Bollinger mid-band. Prior stop was $72.83. Score 5.1/10, high confidence.
Take-profit target: $80.67 (+5.2% upside). Prior stop was $72.83. Stop-loss: $72.83.
Analyst target reached - limited upside remaining; Sector modifier (Real Estate): -1.2; Consecutive earnings misses (2).
National Health Investors, Inc. trades at a P/E of 24.5 (forward 20.9). TrendMatrix value score: 4.0/10. Verdict: Sell.
12 analysts cover NHI with a consensus score of 3.8/5. Average price target: $87.
What does National Health Investors, Inc. do?National Health Investors is a self-managed healthcare REIT with $2.7B in Real Estate Investments across 176 properties...
National Health Investors is a self-managed healthcare REIT with $2.7B in Real Estate Investments across 176 properties in 32 states leased via triple-net leases, plus a $634.3M SHOP segment of 26 senior housing communities. Total revenues were $375.6M in 2025, comprising 72.3% rental income, 21.3% resident fees, and 6.4% interest/other. NHI is selling 32 skilled nursing and 3 independent living facilities to NHC for $560M.